THE ROLES OF VASCULAR ENDOTHELIAL GROWTH-FACTOR (VEGF) AND NEUROGLIA IN RETINAL VASCULARIZATION DURING NORMAL DEVELOPMENT AND IN RETINOPATHY OF PREMATURITY

被引：0
|
作者：
STONE, I
ITIN, A
CHANLING, T
PEER, I
GNESSIN, H
ALON, T
KESHET, E
机构：
[1] HADASSAH UNIV HOSP,JERUSALEM,ISRAEL
[2] UNIV SYDNEY,DEPT ANAT & HISTOL,SYDNEY,NSW 2006,AUSTRALIA
[3] HEBREW UNIV JERUSALEM,DEPT OPHTHALMOL,JERUSALEM,ISRAEL
[4] HEBREW UNIV JERUSALEM,DEPT MOLEC BIOL,JERUSALEM,ISRAEL
来源：
JOURNAL OF NEUROCHEMISTRY | 1995年 / 65卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：S121 / S121
页数：1
相关论文
共 50 条
  • [1] THE ROLES OF VASCULAR ENDOTHELIAL GROWTH-FACTOR AND NEUROGLIA IN THE PATHOGENESIS OF RETINOPATHY OF PREMATURITY
    STONE, J
    PEER, J
    CHANLING, T
    ITIN, A
    GNESSIN, H
    KESHET, E
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1995, 36 (04) : S871 - S871
  • [2] DEVELOPMENT OF RETINAL VASCULATURE IS MEDIATED BY HYPOXIA-INDUCED VASCULAR ENDOTHELIAL GROWTH-FACTOR (VEGF) EXPRESSION BY NEUROGLIA
    STONE, J
    ITIN, A
    ALON, T
    PEER, J
    GNESSIN, H
    CHANLING, T
    KESHET, E
    [J]. JOURNAL OF NEUROSCIENCE, 1995, 15 (07): : 4738 - 4747
  • [3] Progression of retinal vascularization after intravitreal anti-vascular-endothelial growth factor therapy in retinopathy of prematurity
    Mirghorbani, Masoud
    Rashidinia, Ali
    Yaseri, Mehdi
    Zarei, Mohammad
    Khojasteh, Hassan
    Bazvand, Fatemeh
    Modjtahedi, Bobeck S.
    [J]. INTERNATIONAL JOURNAL OF RETINA AND VITREOUS, 2022, 8 (01)
  • [4] Progression of retinal vascularization after intravitreal anti-vascular-endothelial growth factor therapy in retinopathy of prematurity
    Masoud Mirghorbani
    Ali Rashidinia
    Mehdi Yaseri
    Mohammad Zarei
    Hassan Khojasteh
    Fatemeh Bazvand
    Bobeck S. Modjtahedi
    [J]. International Journal of Retina and Vitreous, 8
  • [5] Roles of vascular endothelial growth factor and astrocyte degeneration in the genesis of retinopathy of prematurity
    Stone, J
    ChanLing, T
    Peer, J
    Itin, A
    Gnessin, H
    Keshet, E
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1996, 37 (02) : 290 - 299
  • [6] VASCULAR ENDOTHELIAL GROWTH-FACTOR (VEGF) ANTAGONISTS INHIBIT RETINAL NEOVASCULARIZATION
    AIELLO, LP
    PIERCE, EA
    ROBINSON, GS
    FERRARA, N
    SMITH, LE
    [J]. DIABETES, 1995, 44 : A53 - A53
  • [7] Urinary Vascular Endothelial Growth Factor (VEGF) in Retinopathy of Prematurity and Other Proliferative Retinopathies
    Carl T D'Angio
    Jayakrishna Ambati
    Dale L Phelps
    [J]. Pediatric Research, 1999, 45 : 192 - 192
  • [8] The clinical role of vascular endothelial growth factor (VEGF) system in the pathogenesis of retinopathy of prematurity
    Przemko Kwinta
    Mirosław Bik-Multanowski
    Zofia Mitkowska
    Tomasz Tomasik
    Jacek J. Pietrzyk
    [J]. Graefe's Archive for Clinical and Experimental Ophthalmology, 2008, 246
  • [9] Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity
    Sankar, Mari Jeeva
    Sankar, Jhuma
    Chandra, Parijat
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2018, (01):
  • [10] Urinary vascular endothelial growth factor (VEGF) in retinopathy of prematurity and other proliferative retinopathies
    D'Angio, CT
    Ambati, J
    Phelps, DL
    [J]. PEDIATRIC RESEARCH, 1999, 45 (04) : 192A - 192A
12345